|
FELTON, Calif., Nov. 23, 2022 /PRNewswire/ -- The global clinical trials market valued USD 47.0 billion in 2021 and is anticipated to exhibit growth at a CAGR of 5.8% from 2022 to 2030. The growth of the market is attributed to the growing technological advancements and a rise in demand for clinical trials for carrying out research activities. Moreover, the increasing population coupled with growing chronic diseases is building demand for clinical trials. To access new treatments and medications for surging new diseases, clinical trials are crucial in the healthcare systems.
Key Industry Insights & Findings from the report:
- Based on phase insights. the Phase III segment accounted for 53.4% of the total market share in 2021, contributing to the largest revenue share. The Phase III trials contain huge projects and are the most expensive.
- Phase II segment accounts for 19.4% of the total market share. As per the FDA, over 33% of total medications are carried out under Phase II trials.
- Based on study design insights, the interventional design segment accounted for 45.7% of the total market share in 2021. These studies contribute around 94% of total studies which showcased results.
- The expanded access trials segment is expected to expand at a CAGR of 6% during the forecast period. The growth of the segment is attributed to the rising innovations in clinical trials.
- Based on the indication by study design insights, the interventional trials market for autoimmune/inflammation accumulated 82% of the total market revenue share in the year 2021.
- The observational trials market for autoimmune/inflammation is the second largest segment based on the indications.
- Based on sponsor insights, the pharmaceutical & biopharmaceutical companies account for 70% of the total market revenue share.
- Based on indication insights, the oncology segment accumulated 23.5% of the total market revenue share in 2021.
- Based on regional insights, North America accounted for 50.7% of the total market revenue share in 2021.
Read 120 page full market research report for more Insights, "Clinical Trials Market Size, Share & Trends Analysis Report By Phase, By Study Design, By Indication, By Region And Segment Forecasts From 2022 To 2030", published by Million Insights.
Clinical Trials Market Growth & Trends
During the COVID-19 pandemic, the ways of conducting clinical trials have changed. The regulatory authorities have gained different guidelines for clinical trials during the pandemic virtual trials. The authorities include the U.S. FDA, the European Medicines Agency (EMA), the National Institutes of Health (NIH), and China's National Medical Products Administration. The need to develop and enhance the methods and the scenarios of treatment options are changing which include fast trials with accurate results. The government's support to conduct clinical trials for effective treatments during COVID-19 has boosted the market growth.
For instance, the WHO has launched a new clinical trial named Solidarity, including four treatment options against COVID-19. Moreover, the WHO has declared an international alliance for developing multiple vaccines to prevent the coronavirus disease spread. These factors have managed to help in driving the clinical trials market growth.
Clinical Trials Market Segmentation
Million Insights has segmented the global clinical trials market based on phase, study design, indication, indication by study design, sponsor, service type and region:
Clinical Trials Market - Phase Outlook (Revenue, USD Million, 2017 - 2030)
- Phase I
- Phase II
- Phase III
- Phase IV
Clinical Trials Market - Study Design Outlook (Revenue, USD Million, 2017 - 2030)
- Interventional
- Observational
- Expanded Access
Clinical Trials Market - Indication by Study Design Outlook (Revenue, USD Million, 2017 - 2030)
- Autoimmune/Inflammation
- Rheumatoid arthritis
- Multiple Sclerosis
- Osteoarthritis
- Irritable Bowel Syndrome (IBS)
- Others
- Pain Management
- Oncology
- Blood Cancer
- Solid Tumors
- Other
- CNS Condition
- Epilepsy
- Parkinson's Disease (PD)
- Huntington's Disease
- Stroke
- Traumatic Brain Injury (TBI)
- Amyotrophic Lateral Sclerosis (ALS)
- Muscle Regeneration
- Others
- Diabetes
- Obesity
- Cardiovascular
- Others
Clinical Trials Market - Indication Outlook (Revenue, USD Million, 2017 - 2030)
- Autoimmune/Inflammation
- Interventional
- Observational
- Expanded Access
- Pain Management
- Interventional
- Observational
- Expanded Access
- Oncology
- Interventional
- Observational
- Expanded Access
- CNS Condition
- Interventional
- Observational
- Expanded Access
- Diabetes
- Interventional
- Observational
- Expanded Access
- Obesity
- Interventional
- Observational
- Expanded Access
- Cardiovascular
- Interventional
- Observational
- Expanded Access
- Others
- Interventional
- Observational
- Expanded Access
Clinical Trials Market - Sponsor Outlook (Revenue, USD Million, 2017 - 2030)
- Pharmaceutical & Biopharmaceutical Companies
- Medical Device Companies
- Others
Clinical Trials Market - Service Type Outlook (Revenue, USD Million, 2017 - 2030)
- Protocol Designing
- Site Identification
- Patient Recruitment
- Laboratory Services
- Bioanalytical Testing Services
- Clinical Trial Data Management Services
- Others
Clinical Trials Market - Regional Outlook (Revenue, USD Million, 2017 - 2030)
- North America
- Europe
- U.K.
- Germany
- France
- Spain
- Italy
- Asia Pacific
- India
- Japan
- China
- Australia
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
List of Key Players of Clinical Trials Market
- IQVIA
- PAREXEL International Corporation
- Pharmaceutical Product Development, LLC
- Charles River Laboratory
- ICON Plc
- PRA Health Sciences
- Syneos Health
- Eli Lilly and Company
- Novo Nordisk A/S
- Pfizer
- Clinipace
Read the Latest Press Releases by Million Insights:
- Carbon Dioxide Market - The global carbon dioxide market size is projected to grow by USD 6.83 billion by 2030. It is among the various greenhouse gases responsible for creating a warm atmosphere on earth required to sustain life. One major driving factor for the market during the forecast period is the rising demand for carbon dioxide, especially in the food and beverages, and medical industries for Enhanced Oil Recovery (EOR).
- Active Pharmaceutical Ingredients Market - The global active pharmaceutical ingredients market was valued at USD 209.7 billion and is projected to grow by USD 353 billion at a CAGR of 6% by 2030. Several driving factors for the market that contribute to its constant growth mainly include advancements in the manufacturing of active pharmaceutical ingredients, expansion of the biopharmaceutical sector, and growth in the geriatric population.
- Air Purifier Market - The global air purifier market size was valued at USD 12.26 billion in 2021 and is slated to amass USD 25.97 billion by 2030, exhibiting a CAGR of 8.1% during the forecasted period. Surging concerns regarding health and the growing consciousness among people regarding the need to control air pollution levels have supplemented the adoption of air purifiers in both residential and non-residential settings.
- Ammunition Market - The global ammunition market was valued at USD 22.35 billion and is projected to witness a growth of USD 29.68 billion by 2030 at a CAGR of 3.6%. The evolution and modernization of weapons for armed forces are significant driving factors for the ammunition market growth. Other factors that determine ammunition market growth include the militarization of the police forces, a change in warfare nature, an increase in drug trafficking, and a raise in terrorist activities.
- Collagen Market - The global collagen market size was valued at USD 8.36 billion in 2020 and is expected to showcase a CAGR of 9.0% from 2021 to 2028. The proliferating adoption of collagen in wound healing treatments and cosmetic surgery is accelerating product demand worldwide. Moreover, the growing application areas of collagen such as widespread adoption in the food & beverages sector and the increasing usage in the cosmetics industry are expected to fuel the market growth.
Explore more Market Research Reports by Million Insights, for industry specific reports that provide real-time market trends and forecasts, by condensing the integral elements from our industry reports into bite-sized paragraphs, charts, and tables.
Access More Press Releases
About Million Insights:
Million Insights, is a market research and consulting company, provides syndicated as well as customized research reports and consulting services. We have a comprehensive marketplace, that will enable you to compare data points, before you make a purchase. Enabling informed buying, is our motto and we strive hard to ensure that our clients get to browse through multiple samples, prior to an investment. Service flexibility & the fastest response time are two pillars, on which our business model is founded. Our market research report store includes in-depth reports, from across various industry verticals, such as healthcare, technology, chemicals, food & beverages, consumer goods, material science & automotive.
Contact:
Ryan Manuel
Research Support Specialist, USA
Million Insights
Phone: 1-408-610-2300
Toll Free: 1-866-831-4085
Email: sales@millioninsights.com
Web: https://www.millioninsights.com/
Follow Us: LinkedIn | Twitter
 View original content:https://www.prnewswire.co.uk/news-releases/clinical-trials-market-to-be-worth-78-3-billion-by-2030-million-insights-301685975.html
|
